Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMPL

Impel Pharmaceuticals (IMPL) Stock Price, News & Analysis

Impel Pharmaceuticals logo

About Impel Pharmaceuticals Stock (NASDAQ:IMPL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.04
$0.84
52-Week Range
N/A
Volume
720,000 shs
Average Volume
682,655 shs
Market Capitalization
$956 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMPL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Impel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMPL Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Impel Pharmaceuticals Inc. (IMPLQ)
See More Headlines

IMPL Stock Analysis - Frequently Asked Questions

Impel Pharmaceuticals Inc. (NASDAQ:IMPL) issued its earnings results on Monday, November, 15th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.82) by $0.42. The business earned $0.09 million during the quarter.
Read the conference call transcript
.

Impel Pharmaceuticals (IMPL) raised $80 million in an initial public offering on Friday, April 23rd 2021. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen, Guggenheim Securities and Wedbush PacGrow acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Impel Pharmaceuticals investors own include Athenex (ATNX), NIO (NIO), KLX Energy Services (KLXE), American Airlines Group (AAL), Bolt Biotherapeutics (BOLT), Moderna (MRNA) and Novavax (NVAX).

Company Calendar

Last Earnings
11/15/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMPL
CIK
1445499
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$106.31 million
Net Margins
-353.93%
Pretax Margin
-353.93%
Return on Equity
N/A
Return on Assets
-127.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.19
Quick Ratio
0.13

Sales & Book Value

Annual Sales
$20.99 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.86) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
23,900,000
Free Float
22,418,000
Market Cap
$956 thousand
Optionable
Not Optionable
Beta
1.17
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:IMPL) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners